派格生物医药-B（02565.HK）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

个人与内部人士22.67%
公众及其他20.59%
机构投资者18.15%
私营企业15.04%
其他23.54%

主要股东

主要股东最新
股东
Min XuExecutive Chairman of the Board & GM	14.85%	5,808.19 万	0.00%	+0	2026/06/25
Shanghai Sujie Business Management Consulting Partnership	7.46%	2,917.52 万	0.00%	+0	2026/06/25
Mingxin Capital	6.55%	2,560.52 万	2.36%	-924.69 万	2026/06/25
Yuan-sheng Suzhou Industrial Park Venture Capital Management Co., Ltd.	5.45%	2,131.89 万	2.73%	-1,068.72 万	2026/06/30
Lenovo Group Limited	3.96%	1,548.28 万	0.00%	+0	2025/05/27
Legend Capital Co., Ltd	3.72%	1,454.12 万	0.00%	+0	2025/05/27
Hangzhou Tigermed Consulting Co., Ltd	3.55%	1,388.13 万	0.00%	+0	2025/05/27
China-Singapore Suzhou Industrial Park Ventures Co., Ltd.	3.27%	1,280.58 万	0.00%	+0	2025/05/27
Tasly Pharmaceutical Group Co., Ltd	3.26%	1,274.06 万	0.00%	+0	2025/05/27
Sharelink Capital	2.49%	975.23 万	0.00%	+0	2025/05/27
QHFZ Capital Management Co., Ltd.	2.12%	829.04 万	0.00%	+0	2025/05/27
Shanghai Yaocui Investment Center (Limited Partnership)	1.87%	732.84 万	1.25%	-488.56 万	2026/06/30
Jung-Hsi Liu	1.83%	715.16 万	0.00%	+0	2025/05/27
Bai Lin	1.74%	681.09 万	0.00%	+0	2025/05/27
Yuhong XuNon-Executive Director	1.74%	681.09 万	0.00%	+0	2026/06/25
Xiangjun ZhouNon-Executive Director	1.60%	626.85 万	0.00%	+0	2026/06/25
Suzhou Yipu Equity Investment Fund Management Co., Ltd.	1.24%	483.91 万	0.00%	+0	2025/05/27
Yingke Innovation Asset Management Co., Ltd.	1.14%	445.52 万	3.21%	-1,253.97 万	2026/06/30
Asia Private Equity Capital	0.97%	378.01 万	0.00%	+0	2025/05/27
Qianhai Fangzhou Asset Management Co., Ltd.	0.91%	356.24 万	0.00%	+0	2025/05/27